Interview: Jaime Malet – President, AmCham Spain
Jaime Malet, president of the US Chamber of Commerce (AmCham) in Spain, discusses the importance of the trade relations between the US and Spain, with eight percent of GDP made…
The Indukern Group is a group of Spanish multinational companies founded in 1952 based in Madrid. Its main activities are focused on the pharmaceutical, chemical, food and veterinary industries, among others through its three business areas; Indukern, Calier, and Kern Pharma.
With five business divisions, Indukern is a leading specialist firm in chemicals distribution and value-added activities of formulation, production, and technical advice for various industry sectors.
Calier is a research, development and marketing company of pharmacological and biological products for livestock and pets.
Kern Pharma works in the development, manufacture and marketing of pharmaceutical products, with emphasis on generics and ethicals. It also markets products for the OTC market, biosimilars, women’s health, health and sports nutrition, and production for other companies.
Jaime Malet, president of the US Chamber of Commerce (AmCham) in Spain, discusses the importance of the trade relations between the US and Spain, with eight percent of GDP made…
Carlos Teixeira, CEO of Teva Spain and Portugal, discusses the challenges the generic sector is facing in Spain, which ultimately spurred the company towards other business opportunities, and highlights the…
Eva Prada, director of the British Chamber of Commerce in Spain, discusses trade relations between the UK and Spain and the activities of the Chamber in developing trust-based business relationships…
Regina Múzquiz, director general of the Spanish Biosimilar Medicines Association (BioSim), discusses the importance of biosimilars as a tool to alleviate costs to the healthcare system and save EUR two…
Jose Escribano, founder of Spanish biotech success story ALGENEX, discusses the company’s focus on using insects in its research, difficulties in accessing capital, and its future growth strategy. Can you…
Jaume Pey, director general at the Spanish Association of Self-care (ANEFP), discusses the growth projections of the self-care segment in Spain, the impact that the ‘supresión del control previo sanitario’…
Concha Almarza, general manager at IQVIA Spain, discusses the changes that the Spanish pharmaceutical market has witnessed over the last few years, highlighting the stringent cost-containment measures aimed at improving…
Mariano Esteban Rodriguez, president of the Royal Academy of Pharmacy of Spain (RANF) and of the Institute of Spain (that integrates the 10 Royal Academies), discusses his current research interests…
Walther von Plettenberg, director of the German-Spanish Chamber of Commerce, discusses the strong relationship between the two countries and how Spain’s recent reforms puts the country at an economic advantage.…
Santiago de Quiroga, president editor of leading Spanish pharmaceutical industry newspaper El Global and CEO of healthcare communications group WeCare-u, discusses the country’s health priorities, highlighting the upcoming Personalized Medicine…
Humberto Arnés, director general at Farmaindustria, Spain’s leading pharmaceutical industry association, discusses the dynamics of the Spanish pharmaceutical industry showcasing a growth of 2.7 percent of the total public pharmaceutical…
Ion Arocena, CEO of ASEBIO, Spain’s biotech association, discusses the significant efforts that Spain has made in turning cutting-edge research into successful companies and products and provides an insight into…
See our Cookie Privacy Policy Here
